Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human BLyS receptor-antibody fusion protein in RA (phase II)
CTR20140832Phase 2Completed
- Sponsor
- RemeGen
- Start
- Jan 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of belimumab in rheumatoid arthritis (RA), sponsored by RemeGen. Started Jan 2015; status: completed.
02
Drugs
belimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20140832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140832.